Stay updated on SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial

Sign up to get notified when there's something new on the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T21:45:02.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T04:24:27.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now presents a 403 Forbidden error with a simple header and a Home option. This indicates the study record is inaccessible and the detailed content is no longer displayed.
    Difference
    20%
    Check dated 2026-09-21T22:47:17.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6, signaling a small site release without changes to study information.
    Difference
    0.1%
    Check dated 2026-08-31T16:30:44.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5. This indicates a minor software update and does not modify the study details or visible content.
    Difference
    0.1%
    Check dated 2026-08-10T12:44:26.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    The page revision updated from v3.6.3 to v3.6.4, representing a minor version update to the page rather than a substantive content change.
    Difference
    0.1%
    Check dated 2026-07-27T06:15:47.000Z thumbnail image

Stay in the know with updates to SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page.